Tocilizumab and hyperdynamic syndrome in severe burn patient: is that pouring water on fire?

Ital J Dermatol Venerol. 2023 Dec;158(6):493. doi: 10.23736/S2784-8671.23.07497-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Burns* / complications
  • Burns* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab